These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients. Tornatore KM; Biocevich DM; Reed K; Tousley K; Singh JP; Venuto RC Transplantation; 1995 Mar; 59(5):729-36. PubMed ID: 7886801 [TBL] [Abstract][Full Text] [Related]
8. The impact of triple drug immunosuppression on clinical results of cadaveric kidney transplantation: a comparison of conventional immunosuppression. Sakagami K; Saito S; Shiozaki S; Takasu S; Matsuno T; Fujiwara T; Kusaka S; Uda M; Matsuoka J; Naomoto Y Acta Med Okayama; 1992 Feb; 46(1):53-6. PubMed ID: 1561907 [TBL] [Abstract][Full Text] [Related]
9. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression. Hedman M; Neuvonen PJ; Neuvonen M; Holmberg C; Antikainen M Clin Pharmacol Ther; 2004 Jan; 75(1):101-9. PubMed ID: 14749696 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of methylprednisolone and rejection episodes in kidney transplant patients. Keller F; Hemmen T; Schöneshöfer M; Schwarz A; Offermann G Transplantation; 1995 Aug; 60(4):330-3. PubMed ID: 7652760 [TBL] [Abstract][Full Text] [Related]
12. Compensatory hypertrophy of renal grafts with triple drug therapy. Ishikawa I; Shikura N; Shinoda A; Fukuda Y; Tsugawa R; Suzuki K Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):929-32. PubMed ID: 2250411 [TBL] [Abstract][Full Text] [Related]